Streptococcus pyogenes infects human endometrium by limiting the innate immune response.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
15 02 2021
Historique:
received: 03 06 2019
accepted: 10 12 2020
pubmed: 16 12 2020
medline: 21 9 2021
entrez: 15 12 2020
Statut: ppublish

Résumé

Group A Streptococcus (GAS), a Gram-positive human-specific pathogen, yields 517,000 deaths annually worldwide, including 163,000 due to invasive infections and among them puerperal fever. Before efficient prophylactic measures were introduced, the mortality rate for mothers during childbirth was approximately 10%; puerperal fever still accounts for over 75,000 maternal deaths annually. Yet, little is known regarding the factors and mechanisms of GAS invasion and establishment in postpartum infection. We characterized the early steps of infection in an ex vivo infection model of the human decidua, the puerperal fever portal of entry. Coordinate analysis of GAS behavior and the immune response led us to demonstrate that (a) GAS growth was stimulated by tissue products; (b) GAS invaded tissue and killed approximately 50% of host cells within 2 hours, and these processes required SpeB protease and streptolysin O (SLO) activities, respectively; and (c) GAS impaired the tissue immune response. Immune impairment occurred both at the RNA level, with only partial induction of the innate immune response, and protein level, in an SLO- and SpeB-dependent manner. Our study indicates that efficient GAS invasion of the decidua and the restricted host immune response favored its propensity to develop rapid invasive infections in a gynecological-obstetrical context.

Identifiants

pubmed: 33320843
pii: 130746
doi: 10.1172/JCI130746
pmc: PMC7880408
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Clin Infect Dis. 2013 Sep;57(6):870-6
pubmed: 23645851
J Biol Chem. 2009 Jan 9;284(2):862-71
pubmed: 19001420
J Clin Invest. 1997 Jun 1;99(11):2574-80
pubmed: 9169486
Cell. 2010 Mar 19;140(6):833-44
pubmed: 20303874
Microbiol Spectr. 2019 Jan;7(1):
pubmed: 30737912
Med Microbiol Immunol. 2012 Aug;201(3):357-69
pubmed: 22610375
Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4693-8
pubmed: 20179180
Infect Immun. 2015 Dec;83(12):4750-8
pubmed: 26416912
Am J Infect Control. 2019 Dec;47(12):1493-1499
pubmed: 31296346
Front Public Health. 2018 Mar 09;6:59
pubmed: 29662874
Am J Pathol. 2017 Mar;187(3):605-613
pubmed: 28034602
J Infect Dis. 1996 Apr;173(4):896-900
pubmed: 8603968
Annu Rev Immunol. 2014;32:659-702
pubmed: 24655300
J Immunol. 2009 Nov 1;183(9):5823-9
pubmed: 19812205
Clin Microbiol Infect. 2012 Jul;18(7):702-10
pubmed: 21883669
Am J Pathol. 2020 Apr;190(4):862-873
pubmed: 32200972
Infect Immun. 2000 Nov;68(11):6384-90
pubmed: 11035749
PLoS Med. 2006 Mar;3(3):e53
pubmed: 16401174
Infect Immun. 2015 Oct;83(10):4118-33
pubmed: 26238711
J R Coll Physicians Edinb. 2011 Dec;41(4):339-46
pubmed: 22184573
J Med Microbiol. 2010 Apr;59(Pt 4):442-452
pubmed: 20007764
Mol Microbiol. 2002 Apr;44(1):257-69
pubmed: 11967084
BJOG. 2019 Jan;126(1):44-53
pubmed: 30070056
FASEB J. 2010 Aug;24(8):2839-48
pubmed: 20339024
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32493846
Nat Rev Microbiol. 2011 Sep 16;9(10):724-36
pubmed: 21921933
Hum Reprod Update. 2015 May-Jun;21(3):353-77
pubmed: 25547201
J Biol Chem. 2014 Jul 25;289(30):21003-21015
pubmed: 24904056
JCI Insight. 2016 Jul 7;1(10):e87882
pubmed: 27699220
J Infect Dis. 2003 Feb 15;187(4):597-603
pubmed: 12599076
Infect Immun. 2008 Aug;76(8):3399-404
pubmed: 18490458
Cell Microbiol. 2009 Jan;11(1):138-55
pubmed: 19016794
J Clin Microbiol. 2005 Aug;43(8):4083-91
pubmed: 16081955
Sci Adv. 2018 Oct 31;4(10):eaau4788
pubmed: 30402542
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):12198-201
pubmed: 1281550
Biol Reprod. 2018 Mar 1;98(3):396-407
pubmed: 29155939
Genome Announc. 2015 Jul 16;3(4):
pubmed: 26184934
Clin Microbiol Rev. 2014 Apr;27(2):264-301
pubmed: 24696436
J Clin Microbiol. 1996 Apr;34(4):953-8
pubmed: 8815115
J Immunol. 2017 Feb 1;198(3):1345-1356
pubmed: 28031337
Reprod Sci. 2014 May;21(5):640-7
pubmed: 24177713
J Biol Chem. 2018 Oct 12;293(41):16006-16018
pubmed: 30150299
PLoS Pathog. 2010 Apr 01;6(4):e1000832
pubmed: 20368967
mBio. 2016 Apr 12;7(2):e00020-16
pubmed: 27073088
Proc Natl Acad Sci U S A. 2005 Jun 21;102(25):9014-9
pubmed: 15956184
Mol Microbiol. 2015 Sep;97(6):1209-22
pubmed: 26094503
Placenta. 2013 Jun;34(6):480-5
pubmed: 23562109
J Bacteriol. 1993 Jun;175(11):3628-35
pubmed: 8501066
PLoS One. 2009;4(3):e4769
pubmed: 19274094
Mol Microbiol. 2011 Aug;81(3):588-601
pubmed: 21707787
J Bacteriol. 1965 Feb;89:421-7
pubmed: 14255710
Am J Reprod Immunol. 2014 Feb;71(2):109-19
pubmed: 24330065
Hum Reprod. 2015 Feb;30(2):392-405
pubmed: 25432921
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13855-60
pubmed: 12370433
JCI Insight. 2018 Mar 22;3(6):
pubmed: 29563340
Infect Dis Obstet Gynecol. 2000;8(5-6):217-9
pubmed: 11220480
Clin Infect Dis. 2011 Jul 15;53(2):114-23
pubmed: 21690617
Cell. 2014 Jan 16;156(1-2):97-108
pubmed: 24439371
Methods Enzymol. 1991;204:556-86
pubmed: 1658571
Cell Microbiol. 2005 Sep;7(9):1237-50
pubmed: 16098212
Cell. 2001 Jan 12;104(1):143-52
pubmed: 11163247
Antimicrob Agents Chemother. 2002 Jul;46(7):2269-72
pubmed: 12069987
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
Future Microbiol. 2018 Jan;13:119-134
pubmed: 29226710

Auteurs

Antonin Weckel (A)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.

Thomas Guilbert (T)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.

Clara Lambert (C)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.

Céline Plainvert (C)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.
Centre National de Référence des Streptocoques.
Hôpitaux Universitaires Paris Centre, Cochin, Assistance Publique Hôpitaux de Paris.

François Goffinet (F)

Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.
Faculté de Médecine, Université Paris Descartes, and.
Service de Gynécologie Obstétrique I, Maternité Port Royal, Assistance Publique-Hôpitaux de Paris, Paris, France.

Claire Poyart (C)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.
Centre National de Référence des Streptocoques.
Hôpitaux Universitaires Paris Centre, Cochin, Assistance Publique Hôpitaux de Paris.

Céline Méhats (C)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.

Agnès Fouet (A)

Université de Paris, Institut Cochin, INSERM, U1016, CNRS, UMR8104, Paris, France.
Département Hospitalo-Universitaire Risk & Pregnancy, Port Royal Maternity, Paris, France.
Centre National de Référence des Streptocoques.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH